The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

The following is a summary of "Treatment mechanism and outcome decoupling effects in cognitive therapy, mindfulness-based ...

Hearing loss affects about 30 million people over 12 years old in the U.S. Traditional prescription hearing aids can cost ...

In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...

Weight reduction at one year linked to medication active agent, dosage, treatment indication, persistence of coverage ...

By Dr. Priyom Bose, Ph.D. New study reveals semaglutide outperforms liraglutide in weight loss for obesity, highlighting key ...

Insulin efsitora was able to lower A1C in patients with type 1 diabetes but more patients experienced severe hypoglycemic ...

Eli Lilly and Company (NYSE: LLY) today announced detailed results from the QWINT-5 phase 3 trial evaluating once-weekly ...

Innovent Biologics Inc. (IVBXF.OB) said that Phase 3 clinical trial results demonstrated the superiority of mazdutide to dulaglutide ...

Eli Lilly and Co. (LLY) announced detailed results from the QWINT-2 phase 3 trial evaluating once-weekly insulin efsitora alfa ...

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular ...